Glen Porter, MD
Otolaryngology · Pleasant Grove, UTNPI 1205825973
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,547 of the $4,104 with a category attached, or 62.1%. 7 manufacturers reported payments, led by Intersect ENT, Inc. at 53.8% of the total. Reporting peaked in 2019 at $2,208 and has fallen 93.1% since, to $152 in 2025.
Across 45 payments — averaging $91.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$2K
- Inspire Medical Systems, Inc.$2K
- Sanofi$123
- Stryker$103
- Smith+Nephew$40
- Merck$38
- plus $28 from 1 others
What the payments were for
- Travel & lodging$2,54762%
- Food & beverage$1,55738%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 6 | $2,208 |
| Inspire Medical Systems, Inc. | 33 | $1,564 |
| Sanofi | 1 | $123 |
| Stryker | 1 | $103 |
| Smith+Nephew | 1 | $40 |
| Merck | 2 | $38 |
| Neurent Medical Limited | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$2,133
- SINUVA$2,133
- Inspire$1,076
- DUPIXENT$123
- CLARIFIX CRYOTHERAPY DEVICE$103
How this compares
$4,104 in reported general payments places this provider in the 80th percentile of 104 otolaryngology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 130 | $5,439 |
| Ipratropium Bromide | 42 | $1,341 |
| Mometasone Furoate | 17 | $1,066 |
| Famotidine | 13 | $328 |
| Mupirocin | 22 | $207 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $191 |
| Methylprednisolone | 23 | $179 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Pleasant Grove
- John BitnerLayton$177K
- Steven MillerSalt Lake City$32K
- Michael WilsonSalt Lake City$16K
- Kevin WilsonDraper$13K
- Jerry SonkensSlc$12K
- Matthew DahlSalt Lake City$12K
- Seth RiddleProvo$10K
- Heidi HerasAmerican Fork$9K
- Douglas AndersonOgden$9K
- Scott ShipleyProvo$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.